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Abstract
BACKGROUND: We noticed some smears being cytologically diagnosed as common chronic lymphadenitis that 
cannot be treated with ordinary antibiotics, but succeeded with the anti-tuberculosis drug (ATD), even though it takes 
longer, up to a year or more. Re-examining the MGG smears, we got cases that show the structure, we call Dark 
Oval Bodies (DOB). Most of DOB smears express Interferon (IFN)-γ. IFN-γ plays a role in the protection of infection 
while interleukin (IL)-4 in the opposite.
AIM: The purpose of this study is to determine if there is a difference between an expression of IFN-γ and IL-4 in DOB 
and whether IFN-γ is associated with the protection of the disease.
MATERIALS AND METHODS: Included in this study 41 cases of tuberculous lymphadenopathy with DOB that were 
not successfully treated with common antibiotics but succeeded with ATD. Antigen expression was determined using 
rabbit polyclonal to IFN-γ, (ab9657), and IL-4 (ab9622), Abcam. The expression was categorized as positive and 
negative. The details of the 41 cases were 37 cases (90%) with IFN-γ (+), 4 (10%) with IFN-γ (-), 10 (24%) with IL-4 
(+), and 31 (76%) with IL-4 (-). Thirty cases expressed IFN-γ (+) and IL-4 (-), 1: IFN-γ (-) and IL-4 (+), 8: IFN-γ (+) and 
IL-4 (+), and 2: IFN-γ (-) and IL-4 (-).
RESULTS: IFN-γ is more frequently expressed in DOB compared to IL-4 (p<0.05, the Fisher’s exact tests).
CONCLUSION: IFN-γ can be benefited as the indicator of protection to the tuberculous process.
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Introduction
Tuberculosis (TB) is one of the world’s most 
important public health problems. In 2017, TB caused 
an estimated 1.3 million deaths [1]. The incidence of 
extrapulmonary TB is on a rise over the last few years, has 
increased in parallel with the increase in the incidence 
of HIV/AIDS infection worldwide [2], [3], [4], [5]. TB can 
be found in almost any site in the body and it can affect 
organs other than the lung such as pleura, lymph nodes, 
abdomen, skin, joints, bones, genitourinary tract, and 
meninges [5].
After infection, complex interactions between 
the mycobacterium TB (MTB) bacilli and the human 
body’s immune system begin with phagocytosis 
MTB by macrophages and activate the immune 
response through the release of various cytokines 
and chemokines secreted by different cell types such 
as T helper 1 (Th1, pro-inflammatory) and T helper 2 
(Th2, anti-inflammatory) cells [6]. The theory of balance 
between Th1 and Th2 as a double-edged sword has 
been widely studied, especially the role of IFN-γ and 
Th2 cytokines. MTB is a strong induction of IFN-γ and 
almost common detected in infected hosts but the 
presence of IL-4 varies greatly. The IL-4 cytokines play 
a role in regulating the development of Th1 cells and 
macrophage activity as well as an excessive reducer of 
Th1 work [7], [8], [9].
In general, IFN-γ is considered to protect against 
TB, while IL-4 is associated with a lack of protection 
against TB [7], [10]. The increase of IFN-γ activation 
ultimately leads to affect the destruction of pathogens 
through increased phagocytosis, pro-inflammatory 
responses, and lymphocyte recruitment [11]. IL-4 can 
be considered a potential marker for active TB [12]. The 
increased production of IL-4 could be detected in TB 
patients, especially cavitary TB. The progressive disease, 
reactivation of latent infection, and tissue damage are 
both associated with increased production of IL-4.
We noticed the cases that have been cytologically 
diagnosed as common chronic lymphadenitis which 
cannot be treated with ordinary antibiotics but have 
succeeded with a first-line essential anti- TB drug (ATD), 
although it takes longer, up to a year or more.
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Reexamining the smears, we got some cases 
that showed the structures that are often seen but 
considered meaningless, which we called Dark Oval 
Bodies (DOB). DOBs are small bodies of dark oval-
shaped, bluish-black color contained in macrophages, 
in specimen stained with May Grunewald Giemsa 
(MGG). The smears containing DOB structure usually 
immunocytochemical express IFN-γ and do not show 
necrotic tissue. IFN-γ secreted by CD4 (+) T cells 
played a major role in the protection of infection. IL-4 
is an anti-inflammatory cytokine that has a damaging 
effect on TB that causes deactivation of macrophages 
and suppresses the production of IFN-γ.
Based on this background, we want to 
elaborate if there is a difference between an expression 
of IFN-γ and IL-4 in DOB lesions which will further 
determine whether expression of IFN-γ is associated 
with the protection of the disease.
Materials and Methods
A cross-sectional study on 41 smears collected 
from June 2018 to May 2019, from the Anatomy 
Pathology Diagnostic Center of the Faculty of Medicine, 
University of North Sumatra, Medan, Indonesia. All 
cases were diagnosed as TB based on response to 
the ATD (ex juvantibus). The term ex juvantibus refers 
to the process of making an inference about disease 
causation from an observed response of the disease to 
treatment. The cases were initially treated with common 
antibiotics, however, unsuccessful, but success with 
anti-tuberculous drugs.
Most patients presented with swelling in 
the neck (90%) and the rest were from temporal and 
occipital regions. 44% were adults (19–24 years) and 
17% were children (≤18 years). Sixty-three percent were 
female and 37% were male. In general, patients have 
experienced swelling of the neck on average for 3 weeks 
(range: 2–4 weeks). Acid-fast bacilli were not examined.
Verbal consents were produced by the 
participants. Ethical clearance was obtained from the 
Health Research Ethical Committee of the Faculty 
of Medicine, University of Sumatera/H. Adam Malik 
General Hospital.
Fine-needle aspiration cytology 
examination
Fine-needle aspiration was done by a 
pathologist using a 20-23-G needle (30–50 mm), 10-ml 
of a disposable syringe, and a Comeco Swedia pistolet, 
who fixed the enlarged lymph node and inserted the 
needle in various directions. The specimens were 
immediately stained with a Diff-Quik staining protocol.
Immunocytochemistry examination
After rinsing the slides for a short time in 
phosphate-buffered saline (PBS), incubated the slides 
with hydrogen peroxide for 30 min to block endogenous 
peroxidase activity. After taking the microwave antigen, 
blocking the items with 5% normal serum horse (NHS) 
for 15 min, the slides were then treated with primary 
antibodies – rabbit polyclonal to anti-interferon-γ (IFN-γ, 
ab9657), and rabbit polyclonal to anti-interleukin-4 (IL-4, 
ab9622), both from Abcam, London, England, at 1/100 
dilution overnight, then treated with Dako Real En Vision.
The antigen is visualized with diaminobenzidine 
(DAB) and anti-staining with hematoxylin.
Evaluation of immunostaining
Stained stuff was categorized as positive and 
negative assessment.
Statistical analysis
Fisher’s exact tests were used to determine 
the relationship between two variables. p < 0.05 was 
considered significant.
Cytology
Cytological characteristics of DOB of 
tuberculous lymphadenitis are observed in Figure 1.
Expression of IFN-γ and IL-4 in DOB
Figure 2 showed the expression of IFN-γ in 
most of the tuberculous lymphadenitis with DOB. 
Figure 3 showed the expression of IL-4 in most 
of the tuberculous lymphadenitis with DOB.
The details of the 41 cases were 37 cases 
(90%) with positive expressions of IFN-γ, four cases 
Figure 1: Aspirate of the small dark oval body inside grouped some 
macrophages (DOB) (MGG, ×400)
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Figure 2: Positive IFN-γ expression (ICC, ×400)
(10%) with negative IFN-γ, ten cases (24%) with 
positive IL-4, and 31 cases (76%) with negative IL-4. 
Thirty cases expressed IFN-γ (+) and did not express 
IL-4 (-), one case of IFN-γ (-) and IL-4 (+), eight cases 
of IFN-γ (+) and IL-4 (+), and two cases of IFN-γ (-) and 
IL-4 (-).
IFN-γ was more frequently expressed in DOB 
lesion when compared to IL-4 (p<0.05).
Figure 3: Negative IL-4 expression (ICC, ×400)
Discussion
In tuberculous lymphadenitis, little is known 
about the mechanisms whereby the human immune 
system controls the influence of specific cytokines. 
The formation of granulomas containing multinucleated 
giant cells is one of the hallmarks of an effective immune 
response against M. tuberculosis [2].
In our previous study on patients with DOB 
in which the aspirate was serous with or without 
blood, the administration of ATDs showed significant 
improvement [13], so we suggested that DOB was 
involved in the tuberculous process.
In our 41 cases of DOB, 37 (90%) expressed 
IFN-γ, and 31 (76%) did not IL-4. Our findings are in 
accordance with those of the previous studies, suggesting 
that IFN-γ is required to control this infection [14]. 
Thus, this study confirms previous observations that 
patients with TB produce large amounts of IFN-γ and 
low levels of IL-4 [15]. The increase of IFN-γ could be 
associated with protective effects for TB. IL-4 cytokine 
is secreted by Th2 cells can induce anti-inflammatory 
effects by decreasing the activation of macrophages 
through the classical pathway [15]. It was reported 
that overexpression of IL-4 increased the severity of 
TB [16], [17]. In other words, if IL-4 is not expressed the 
severity decreases. It is in accordance with our study 
where IL-4 was not expressed in 31 (76%) of cases.
Atypical mycobacterial TB also known as 
mycobacterium avium complex (MAC), nontuberculous 
mycobacteria (NTM), environmental mycobacteria, 
atypical mycobacteria, and mycobacteria other than 
TB (MOTT) is mycobacteria which do not cause TB 
or leprosy (also known as Hansen’s disease). MAC 
do cause pulmonary diseases that resemble TB [18]. 
Mycobacteriosis is usually meant to exclude TB. They 
occur in many animals, including humans.
Treatment of atypical mycobacterial infections 
depends on the infecting organism and the severity 
of the infection. In most cases a course of antibiotics 
is necessary. These include rifampicin, ethambutol, 
isoniazid, minocycline, ciprofloxacin, clarithromycin, 
azithromycin, and cotrimoxazole. Usually, treatment 
consists of a combination of drugs.
Although lesions with DOB can be treated with 
ATD, most cases require a longer time even up to 1 
year or more. We cannot elucidate why this happened. 
The possible explanation is that the lesions with DOB 
are not only caused by TB but also by MAC and 
that MAC can also be treated with ATD even though 
the duration of treatment is longer. If the possibility 
is true, then DOB can be thought of as a cytological 
description of MAC. In cases of presumed tuberculous 
neck lymph node infections, differential diagnosis of 
atypical mycobacterial lymphadenitis should always 
be considered, because medical treatment differs 
fundamentally.
In summary, our data suggest that the 
expression of IFN-γ in DOB may be an immune 
response to resolve the infection. These findings have 
implications in designing new immune-intervention 
strategies for TB by modulation of the host immune 
response, using IFN-γ and anti-IL-4.
Conclusion
IFN-γ can be benefi ted as an indicator of 
protection to the tuberculous process, where IFN-γ is more 
frequently expressed in DOB lesion compared to IL-4.
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